Association between serum vitamin D levels and cardiovascular disease risk in patients with hyperuricemia: A

Huan Lei1, Biyue Wei1, Xiao Dong1

  • 1Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Harbin Medical University, Heilongjiang, China.

Plos One
|April 3, 2026
PubMed

Insights

Vitamin D deficiency (VDD) is linked to higher cardiovascular disease (CVD) prevalence and severity in hyperuricemia (HUA) patients. Maintaining sufficient vitamin D levels may reduce CVD risk in this population.

Area of Science:

  • Endocrinology
  • Cardiology
  • Metabolic Diseases

Background:

  • Hyperuricemia (HUA) is an independent cardiovascular disease (CVD) risk factor.
  • Low vitamin D levels are associated with increased CVD risk.
  • The combined impact of HUA and vitamin D status on CVD is not well understood.

Purpose of the Study:

  • To investigate the association between vitamin D levels and CVD in HUA patients.
  • To determine if vitamin D deficiency (VDD) correlates with increased CVD prevalence and severity.
  • To explore the relationship between low vitamin D and coronary artery stenosis.

Main Methods:

  • Cross-sectional study of 483 HUA patients.
  • Stratification into VDD, insufficiency, and sufficiency groups based on 25(OH)D levels.
  • Analysis of CVD prevalence, Gensini scores, and correlation with vitamin D and metabolic markers.

Main Results:

  • CVD prevalence and Gensini scores were significantly higher in the VDD group compared to the sufficiency group.
  • Serum 25(OH)D showed negative correlations with glycated hemoglobin, total cholesterol, triacylglycerol, and Gensini score.
  • Vitamin D status was an independent protective factor against CVD (OR=0.94), while age was a risk factor (OR=1.06).

Conclusions:

  • Patients with HUA and VDD exhibit higher CVD prevalence and coronary artery stenosis.
  • Vitamin D status is independently associated with reduced CVD risk in HUA patients.
  • Age is an independent risk factor for CVD in HUA patients.

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
849
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
970
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
723
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
770
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
625